Modern science enables accurate lung cancer screening

This is an automatically translated article.

The article was professionally consulted by Specialist Doctor I Le Thien Quang - Internal Oncologist - Department of Medical Examination & Internal Medicine - Vinmec Da Nang International Hospital
Lung cancer is a dangerous disease, currently with the second highest incidence and mortality rate of all cancers. With the advancement of medicine, lung cancer can be accurately screened with modern imaging equipment. So how is lung cancer screened, let's find out!

1. What is lung cancer?


Cancer is a condition in which cells grow, multiply uncontrollably, invade surrounding areas and metastasize. Lung cancer is of two types, small cell lung cancer and non-small cell lung cancer.
According to the latest statistics in 2018, each year there are nearly 24,000 new cases of lung cancer and over 20,000 deaths, enough to see the danger of this disease.
sàng lọc ung thư phổi
Ung thư phổi cần sàng lọc sớm

2. Why screen for lung cancer?


Any cancer should be screened for early detection, treatment at the early stages to achieve the best results, reduce treatment costs, limit complications, and improve quality of life. With a disease with a high incidence and mortality rate like lung cancer is no exception. If detected late, lung cancer treatment results are extremely limited, the cost is very high, the quality of life is reduced and the patient's remaining time is not much.

3. Accurate lung cancer screening with modern imaging equipment


Classical lung cancer screening can be done by methods such as chest X-ray, sputum histopathology, but these two methods, whether used alone or at the same time, are very ineffective and does not reduce the risk of dying from lung cancer.
With the development of medicine, more advanced and modern methods were born and today's highest technology, which has proven to be effective, is low-dose computed tomography (LDCT). ) thoracic cavity.
Low dose computed tomography is a special technique, combining modern equipment, complex computer algorithms, creating many thin slices to early detect even the smallest lesions, while reducing the amount of radiation the patient is subjected to compared to conventional computed tomography, improving patient safety.

4. Who should be screened for lung cancer?

According to the latest recommendations of the American Cancer Society, lung cancer screening should be conducted annually, using low-dose computed tomography, for the following subjects:
Age 55 - 74 years , in good health Current smoker, or has quit for less than 15 years Smokes 30-pack-years* or more Accepts to quit if still smokes Counseled , clearly explaining the benefits, limitations, and risks of lung cancer screening. Lung cancer screening can be carried out at a center with advanced and modern human resources, equipment, and facilities * Number of packages -year of cigarettes is calculated according to the formula:
(Number of packs-years) = (Number of packs/day) x (Number of years smoked)
1 includes 20 cigarettes

5. What are the benefits and risks of lung cancer screening?

Benefits:
Conventional computed tomography has the ability to detect very small abnormalities in the lungs, with low-dose computed tomography, the effect is much greater, easily detecting the disease in the earliest stage, the easiest to treat, and the most effective. The imaging process is relatively fast, easy to perform even for patients who have difficulty when asked to hold their breath (patients will be asked to hold their breath for a very short time, about 5-10 seconds during the scan). . The procedure is painless, non-invasive, and low-dose computed tomography does not require the use of contrast agents. There is no residual radiation after the scan. Radiation used in low-dose computed tomography does not cause immediate side effects, does not affect metal objects in the patient (such as pacemakers, artificial joints,...). Low-dose computed tomography uses a much lower dose of radiation than standard computed tomography. Lung cancer screening with low-dose computed tomography has been shown to reduce mortality in high-risk populations. When cancer is detected, it is often detected at a very early stage, making treatment more effective and easier. Risk:
False positives can occur when the end result is abnormal, but cancer is not present. At this point, additional tests may be needed, possibly repeating the computed tomography scan or performing an invasive test, such as a lung biopsy. In this case, the patient will be carefully consulted. False negative, i.e. the end result is completely normal, but the patient actually has cancer. Not all cancers detected by low-dose computed tomography are at an early stage. If the disease is already at a late stage, the treatment results will be very limited, the survival time is short and the quality of life is reduced. Therefore, early cancer screening is very important.
sàng lọc ung thư phổi
Sàng lọc ung thư phổi với máy chụp CT 128 lát
Understanding the importance as well as the need for early screening for lung cancer, Vinmec International Hospital is currently implementing a Lung Cancer Screening Package, patients will be examined and consulted by a team of leading experts. Experienced, comprehensive cooperation with domestic and international hospitals, with modern facilities, leading high-tech equipment in Vietnam (especially 128-slice CT scanner), meeting fully respond to the motto of individualizing each patient, towards the goal of all for the health and quality of life of the patient.

Please dial HOTLINE for more information or register for an appointment HERE. Download MyVinmec app to make appointments faster and to manage your bookings easily.

8 reads

Relating articles
  • Gefitinib
    Uses of Gefitinib

    Gefitinib is an anti-cancer drug for locally advanced or metastatic non-small cell lung cancer. Complying with indications and doses of Gefitinib will help patients improve treatment efficiency and ensure safety for health.

    Readmore
  • thuốc allipem
    Uses of Allipem

    Allipem 500mg is commonly used to treat patients with locally advanced non-small cell lung cancer or metastases to other areas of the body. The drug can be combined with Cisplatin to increase the effectiveness of treatment, but it is necessary ...

    Readmore
  • ung thư phổi không tế bào nhỏ giai đoạn di căn
    Types of lung cancer: Differences between men and women

    Lung cancer is the second most common cancer in both men and women. It is by far the leading cause of cancer death in both sexes, accounting for nearly 25% of all cancer deaths.

    Readmore
  • Dấu hiệu ung thư phổi
    Lung cancer in women: 3 basic things to know

    Lung cancer in women is often attributed to smoking behavior and it is this thinking that pushes lung cancer patients into a state of stigma by those around them.

    Readmore
  • amivantamab
    Uses of Amivantamab

    Amivantamab is a new drug introduced in the treatment of patients with non-small cell lung cancer. Medicines are used in cases where other treatments have not been effective, helping to control the disease and increase life expectancy.

    Readmore